Primary |
Precocious Puberty |
54.1% |
Product Used For Unknown Indication |
25.5% |
Drug Use For Unknown Indication |
5.8% |
Attention Deficit/hyperactivity Disorder |
2.0% |
Seasonal Allergy |
1.6% |
Vitamin Supplementation |
1.6% |
Epilepsy |
1.3% |
Headache |
1.1% |
Hypersensitivity |
1.1% |
Hormone Level Abnormal |
0.9% |
Endometriosis |
0.7% |
Gastrooesophageal Reflux Disease |
0.7% |
Juvenile Idiopathic Arthritis |
0.7% |
Anxiety |
0.4% |
Asthma |
0.4% |
Blood Growth Hormone |
0.4% |
Complex Partial Seizures |
0.4% |
Convulsion |
0.4% |
Depression |
0.4% |
Hypertension |
0.4% |
|
Injection Site Pain |
9.9% |
Incorrect Dose Administered |
9.2% |
Drug Dispensing Error |
8.5% |
Weight Increased |
7.7% |
Pyrexia |
6.3% |
Injection Site Abscess |
5.6% |
Injection Site Swelling |
5.6% |
Convulsion |
4.9% |
Drug Dose Omission |
4.9% |
Headache |
4.2% |
Drug Ineffective |
3.5% |
Injection Site Abscess Sterile |
3.5% |
Injection Site Reaction |
3.5% |
Mood Swings |
3.5% |
Rash |
3.5% |
Urticaria |
3.5% |
Wrong Drug Administered |
3.5% |
Abscess Sterile |
2.8% |
Hypertension |
2.8% |
Medication Error |
2.8% |
|
Secondary |
Precocious Puberty |
53.2% |
Product Used For Unknown Indication |
10.6% |
Uterine Leiomyoma |
6.4% |
Drug Use For Unknown Indication |
3.5% |
Anaemia |
2.8% |
Headache |
2.8% |
Vitamin Supplementation |
2.8% |
Hypersensitivity |
2.1% |
Menorrhagia |
2.1% |
Attention Deficit/hyperactivity Disorder |
1.4% |
Endometriosis |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hypertension |
1.4% |
Left Ventricular Hypertrophy |
1.4% |
Migraine Prophylaxis |
1.4% |
Thermal Burn |
1.4% |
Vaginal Haemorrhage |
1.4% |
Asthma |
0.7% |
Breast Enlargement |
0.7% |
Hypothyroidism |
0.7% |
|
Weight Increased |
13.6% |
Drug Dispensing Error |
11.4% |
Injection Site Pain |
11.4% |
Incorrect Dose Administered |
6.8% |
Drug Effect Decreased |
4.5% |
Hormone Level Abnormal |
4.5% |
Incorrect Drug Dosage Form Administered |
4.5% |
Menstrual Disorder |
4.5% |
Overdose |
4.5% |
Pharyngitis Streptococcal |
4.5% |
Precocious Puberty |
4.5% |
Rash Pruritic |
4.5% |
Wrong Drug Administered |
4.5% |
Arthralgia |
2.3% |
Bone Cyst |
2.3% |
Disease Recurrence |
2.3% |
Drug Ineffective |
2.3% |
Drug Level Changed |
2.3% |
Drug Name Confusion |
2.3% |
Dyspnoea |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
73.3% |
Convulsion |
13.3% |
Growth Hormone Deficiency |
6.7% |
Metastases To Bone |
6.7% |
|
Convulsion |
33.3% |
Osteonecrosis Of Jaw |
33.3% |
Snoring |
33.3% |
|